DR. MORT ROTHBARD JOINS VIRATECH ADVISORY BOARD
STOCKTON, CALIFORNIA/January 8, 2013 / Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.
Morton Rothbard MD, PhD was the Founder of In-Shape City Health Clubs (Inshapeclubs.com), with over 65 Athletic Clubs in the USA. He was awarded the recognition as “Business Man of the Year” in the city of Stockton, California.
Dr. Rothbard received his Bachelor of Science from Syracuse University, his Master’s degree from Northeastern University in 1954, and his PhD in Bio-Chemistry in 1957 from Notre Dame. He received his MD from St. Louis University in 1962, with his Internship at Jewish Hospital of St. Louis, and Residency in Urology at NYU, Bellevue Hospital New York and at Stanford, Stanford Presbyterian Hospital in San Francisco. He has published an article in the Journal of Cancer.
Dr. Rothbard did his post-Doctoral research at the University of Wisconsin McArdle Cancer Labs, with a special interest in cancer. He practiced urology for about 20 years. Then he started a business chain of health clubs. “I am interested in the overall health of people and new technologies for health”, stated Dr. Rothbard, “I do have a special interest in cancer, not only because of my past research in this field, also from my private practice experience. With my background in Biochemistry, I understand the Viratech interest in health maintenance, which was my interest in the health and fitness industry and its ability to reach hundreds of thousands, and not simply hundreds of people in a medical office, that is why I started health clubs many years ago.”
“Dr. Rothbard’s expertise in cancers of the bladder, kidney, and prostate, due to his background in urology and biochemistry, is very complimentary to Viratech’s interests in early screening of these cancers,” states Dr. Buckman, CEO of Viratech.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Kevin Buckman MD
Email Contact: firstname.lastname@example.org
Tel: 209 477 3030
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.